J.‐F. Rahier

1.1k total citations
14 papers, 446 citations indexed

About

J.‐F. Rahier is a scholar working on Epidemiology, Genetics and Surgery. According to data from OpenAlex, J.‐F. Rahier has authored 14 papers receiving a total of 446 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Epidemiology, 6 papers in Genetics and 4 papers in Surgery. Recurrent topics in J.‐F. Rahier's work include Inflammatory Bowel Disease (6 papers), Microscopic Colitis (4 papers) and Liver Diseases and Immunity (3 papers). J.‐F. Rahier is often cited by papers focused on Inflammatory Bowel Disease (6 papers), Microscopic Colitis (4 papers) and Liver Diseases and Immunity (3 papers). J.‐F. Rahier collaborates with scholars based in Belgium, France and United Kingdom. J.‐F. Rahier's co-authors include Édouard Louis, Alfons Van Gompel, Michel Moutschen, Marc Van Ranst, Filip De Keyser, Pierre Masson, Siegfried Segaert, J F Colombel, Simon Travis and Yazdan Yazdanpanah and has published in prestigious journals such as Gastroenterology, Gut and Alimentary Pharmacology & Therapeutics.

In The Last Decade

J.‐F. Rahier

14 papers receiving 437 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
J.‐F. Rahier Belgium	8	190	166	160	114	88	14	446
Emanuelle Bellaguarda United States	10	106 0.6×	198 1.2×	184 1.1×	145 1.3×	38 0.4×	24	488
K.H. Katsanos Greece	5	153 0.8×	362 2.2×	296 1.9×	97 0.9×	50 0.6×	14	501
María Dolores Martin‐Arranz Spain	13	162 0.9×	384 2.3×	248 1.6×	254 2.2×	102 1.2×	88	638
Jochen Klaus Germany	13	128 0.7×	277 1.7×	175 1.1×	125 1.1×	22 0.3×	34	526
Gianluca Andrisani Italy	15	136 0.7×	390 2.3×	346 2.2×	220 1.9×	39 0.4×	48	721
Nicolas de Suray Belgium	4	138 0.7×	402 2.4×	362 2.3×	101 0.9×	42 0.5×	6	522
T Fukunishi Japan	11	153 0.8×	73 0.4×	216 1.4×	95 0.8×	49 0.6×	45	625
Jacqueline Jossen United States	10	115 0.6×	263 1.6×	204 1.3×	86 0.8×	43 0.5×	13	358
Cristina Alba Spain	10	81 0.4×	326 2.0×	238 1.5×	104 0.9×	28 0.3×	22	502
K. Tyson Thomas United States	6	127 0.7×	101 0.6×	37 0.2×	163 1.4×	122 1.4×	7	535

Countries citing papers authored by J.‐F. Rahier

Since Specialization

Citations

This map shows the geographic impact of J.‐F. Rahier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.‐F. Rahier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.‐F. Rahier more than expected).

Fields of papers citing papers by J.‐F. Rahier

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J.‐F. Rahier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.‐F. Rahier. The network helps show where J.‐F. Rahier may publish in the future.

Co-authorship network of co-authors of J.‐F. Rahier

This figure shows the co-authorship network connecting the top 25 collaborators of J.‐F. Rahier. A scholar is included among the top collaborators of J.‐F. Rahier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J.‐F. Rahier. J.‐F. Rahier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Vermeire, Séverine, Édouard Louis, Olivier Dewit, et al.. (2017). Clinical and scientific aspects related to biosimilars in inflammatory bowel diseases (IBD): position document of the Belgian IBD Research & Development Group (BIRD).. PubMed. 78(1). 26–9. 4 indexed citations

Baert, Filip, Cathérine Reenaers, Peter Bossuyt, et al.. (2017). P438 Adalimumab dose escalation and de-escalation in ulcerative colitis: incidence and predictors of success. A real life Belgian cohort study. Journal of Crohn s and Colitis. 11(suppl_1). S299–S299. 1 indexed citations

Seirafi, Mariam, Bénédicte De Vroey, Philippe Seksik, et al.. (2014). Factors associated with pregnancy outcome in anti‐TNF treated women with inflammatory bowel disease. Alimentary Pharmacology & Therapeutics. 40(4). 363–373. 65 indexed citations

Marthey, Lysiane, Christine Mateus, Maria Nachury, et al.. (2014). P202 Ipilimumab colitis: a GETAID multicentric study. Journal of Crohn s and Colitis. 8. S146–S146. 2 indexed citations

Assche, Gert A. Van, Édouard Louis, Simon Everett, et al.. (2011). Effects of Infliximab Therapy on Transmural Lesions Assessed by MRI Enteroclysis in Patients With Ileal Crohn's Disease: The ACTIF Study. Gastroenterology. 140(5). S–73. 2 indexed citations

Rahier, J.‐F., Laurent Dubuquoy, J F Colombel, et al.. (2011). Increased lymphatic vessel density and lymphangiogenesis in inflammatory bowel disease. Alimentary Pharmacology & Therapeutics. 34(5). 533–543. 79 indexed citations

Rahier, J.‐F., Michel Moutschen, Alfons Van Gompel, et al.. (2010). Vaccinations in patients with immune-mediated inflammatory diseases. Lara D. Veeken. 49(10). 1815–1827. 143 indexed citations

Rahier, J.‐F., Tom G. Moreels, Paul De Munter, & Geert D’Haens. (2010). Prevention of opportunistic infections in patients with inflammatory bowel disease and implications of the ECCO consensus in Belgium.. PubMed. 73(1). 41–5. 6 indexed citations

Kopylov, Uri, Gerassimos J. Mantzaris, K.H. Katsanos, et al.. (2010). The efficacy of shortening the dosing interval to once every six weeks in Crohn’s patients losing response to maintenance dose of infliximab. Alimentary Pharmacology & Therapeutics. 33(3). 349–357. 75 indexed citations

10.

Rahier, J.‐F., et al.. (2009). The European (ECCO) Consensus on infection in IBD: what does it change for the clinician?. Gut. 58(10). 1313–1315. 31 indexed citations

11.

Rahier, J.‐F., Yazdan Yazdanpanah, N. Viget, Simon Travis, & J.F. Colombel. (2009). Review article: influenza A (H1N1) virus in patients with inflammatory bowel disease. Alimentary Pharmacology & Therapeutics. 31(1). 5–10. 17 indexed citations

12.

Rahier, J.‐F., et al.. (2004). Chronic lymphocytic leukemia with portal hypertension and without liver involvement: a case report underlining the roles of increased spleno-portal blood flow and "protective" sinusoidal vasoconstriction.. PubMed. 66(4). 303–6. 7 indexed citations

13.

Henrion, Jean, M. Hautekèete, R Brenard, et al.. (1996). [Fulminant or sub-fulminant hepatocellular failure caused by metastatic invasiveness of the liver: an other cause of hypoxic hepatitis?].. PubMed. 20(6-7). 535–43. 1 indexed citations

14.

Otte, J. B., Jean de Ville de Goyet, Bernard de Hemptinne, et al.. (1987). Liver transplantation in children: report of 2 1/2 years' experience at the University of Louvain Medical School in Brussels.. PubMed. 19(4). 3289–302. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact